Stories

Texas Man Who Claimed Girlfriend Was Forced to Take Abortion Pills Drops Case After His Own Domestic Violence Record Is Raised

Roselydah Eunice
By Roselydah Eunice 7 min read

This article was originally published on Crafting Your Home. A human contributor also wrote and edited the post.

A closely watched federal lawsuit accusing a California doctor of supplying abortion pills connected to an allegedly coerced abortion has ended without a judge deciding what happened or who, if anyone, should be held responsible.

Jerry Rodriguez ended his lawsuit voluntarily on June 30, 2026, in the Southern District of Texas. He had sued Dr. Remy Coeytaux, alleging that the estranged husband of Rodriguez’s girlfriend obtained abortion medication from the physician and pressured the woman to take it.

The dismissal closed one of the first major attempts to connect alleged reproductive coercion with the expanding interstate market for abortion medication. It also left families, physicians, and lawmakers without a clear answer to a difficult question: When someone allegedly misuses a prescription to control a pregnancy, how far should legal responsibility extend beyond the suspected abuser?

The case ended abruptly.

Rodriguez filed the case in July 2025 and later expanded his allegations through a first amended federal complaint. He sought damages from Coeytaux and an order preventing the doctor from sending additional abortion medication into Texas.

His complaint described two pregnancies involving the same woman. Rodriguez alleged that her estranged husband obtained medication connected to the first pregnancy in September 2024 and pressured her to use it. The complaint described a second abortion in January 2025, but its language did not present both events in precisely the same way.

None of those allegations reached a trial. The dismissal was without prejudice, which generally allows a qualifying claim to be filed again, although procedural deadlines and other legal barriers may still apply. Each side agreed to cover its own legal costs. The timing attracted attention. Coeytaux’s lawyers had opposed Rodriguez’s effort to revise the case one day before he dismissed it. The defense argued that Rodriguez faced problems involving standing, the effective date of Texas law, and his eligibility to seek certain remedies.

Coeytaux’s attorneys also raised Rodriguez’s history involving family violence. Texas lawmakers restricted who may benefit from parts of the state’s abortion-pill enforcement system, creating a potential obstacle for plaintiffs with certain domestic violence or coercion records.

The judge never decided that issue. The voluntary dismissal arrived before the court ruled on the proposed amendment, evaluated the evidence, or determined whether Coeytaux had violated any law. That distinction matters. A dismissed lawsuit does not establish that the accusations were false, nor does it validate them.

Another coercion claim continues.

A second Texas case could provide a more direct test of how courts handle allegations that abortion medication was administered without consent. Liana Davis alleges that former partner Christopher Cooprider secretly placed abortion medication in a hot drink after she refused to end her pregnancy. Her lawsuit also names Aid Access and physician Rebecca Gomperts, claiming they helped provide the medication.

Cooprider disputes Davis’ account. His response presents a different version of the events, making phone messages, delivery information, medical evidence, and witness testimony potentially central to the outcome.

The case remains actively litigated in the Southern District of Texas. The docket included continuing disputes over electronic evidence, phone access and confidential information through July 9, 2026. No final ruling has established that Davis was secretly drugged or that the telehealth defendants knew about an alleged plan to deceive her.

That case highlights the legal distance between an alleged abuser and a remote clinician. A person who secretly gives medication to a pregnant partner would have direct involvement in the alleged harm. Holding a physician or a telehealth organization responsible requires additional evidence of what the provider knew, who completed the consultation, and whether warning signs indicated that someone else controlled the order.

Courts may also examine who supplied the patient information, who paid for the medication, where it was delivered, and whether the provider communicated privately with the pregnant patient. Those questions could determine whether these cases remain disputes between intimate partners or become precedents capable of reshaping telehealth abortion nationwide.

Texas targets mailed medication.

The litigation comes as Texas expands its effort to stop abortion pills from entering the state. A Texas law took effect on Dec. 4, 2025, allowing private civil actions against people involved in manufacturing, prescribing, distributing or mailing abortion-inducing drugs into Texas. Pregnant patients who obtain or use the medication are exempt from being sued under the statute.

Relatives connected to a pregnancy may seek minimum damages reaching $100,000 from a defendant if they prevail. The law can also reach physicians, companies, friends, or relatives accused of helping someone obtain abortion medication.

Supporters view private lawsuits as a way to enforce Texas’ abortion ban against providers who remain beyond the direct reach of state regulators. Critics argue that the financial threat could discourage lawful providers in other states from offering care, even when shield laws protect their conduct in their home states.

That conflict has created a national test of state power. A physician may act lawfully while sitting in California or New York, yet Texas may claim that the same transaction becomes unlawful when medication reaches a Texas address.

Federal rules still allow mailing.

Side panel view of a United States Postal Service mail truck emphasizing its logo.
Image Credit: Giant Asparagus/Pexels

Mifepristone is approved for use with misoprostol to end an intrauterine pregnancy through 10 weeks. Under federal mifepristone dispensing rules, certified prescribers may provide the drug, while certified pharmacies or qualified providers may dispense it in person or by mail.

The program requires the patient and health care provider to review and sign an agreement. Treatment risks must be explained before the prescription is issued, and certified pharmacies must use shipping services that provide tracking information.

Those requirements depend heavily on truthful identity information and voluntary participation. Coercion cases expose the system’s hardest vulnerability: safeguards designed for a willing patient may not detect a controlling partner who allegedly impersonates, pressures or monitors that patient.

The stakes are substantial because telehealth now serves thousands of patients in states with abortion bans. In 2025, telehealth abortions reached 91,000 among patients living in states with total bans, up from 74,000 the previous year.

A nationwide in-person requirement could make third-party impersonation more difficult in some circumstances. It could also force consenting patients to travel, miss work, arrange child care, or disclose their plans to controlling partners. The Supreme Court temporarily preserved existing rules on May 14 after a lower court attempted to restrict telehealth prescribing and mail delivery. The justices did not permanently settle the dispute, leaving the larger federal challenge unresolved.

Consent remains the dividing line.

Reproductive coercion extends beyond pressure to have an abortion. It can include contraceptive sabotage, forced pregnancy, threats to continue a pregnancy, or efforts to prevent someone from seeking medical care. Public health guidance recognizes that reproductive coercion includes pregnancy pressure, making consent the central issue rather than the outcome an abuser prefers.

That broader definition should guide the legal response. A credible system must protect a person who is being forced to terminate a pregnancy and a person who is being prevented from ending one.

The Rodriguez case disappeared before a court could examine those competing concerns. The Davis litigation may eventually provide clearer answers, but its accusations remain disputed.

For now, the cases show that one partner’s alleged abuse cannot automatically prove wrongdoing by a remote physician. Courts must still determine who placed the order, who communicated with the provider, what each defendant knew, and whether the requested legal remedy addresses the alleged harm.

The central principle remains uncomplicated even as the litigation grows more complex: No person should control another person’s pregnancy through threats, deception or secret medication.

If you like what you just read, then subscribe to our newsletter and follow us on social media.

Author
Roselydah Eunice

Roselydah Eunice is a writer and sports professional. Since 2016, she has specialized in creating engaging social media content, authentic journal-style reflections, and persuasive commentary designed to spark meaningful discussions. A former professional player in the FKF Women's Premier League and a certified football coach, Roselydah uniquely blends her passion for sports leadership with a gift for clear storytelling. Her goal is always to build authentic connections and write content that resonates deeply with her readers.

Leave a Reply

Your email address will not be published. Required fields are marked *